October 17, 2005

EU body gives old pain drugs clean bill of health

LONDON (Reuters) - Europe's drug watchdog said on Monday it
had no new safety concerns over older pain medicines like
ibuprofen and naproxen, following an extensive review of side
effect issues.

Non-selective NSAIDs, or non-steroidal anti-inflammatory
drugs, remain important treatments for arthritis and other
painful conditions, the European Medicines Agency said in a
statement.

Agency experts carried out an extensive study into the
safety of the drugs at the request of the European Commission,
in the wake of the withdrawal of Merck & Co Inc's newer but
related drug Vioxx last year.

Their study did not find any new safety issues with
non-selective NSAIDs regarding cardiovascular, gastrointestinal
or serious skin reaction side effects.